There is a wealth of evidence that methylphenidate can improve attention-deficit/hyperactivity disor...

On Friday, the Food and Drug Administration (FDA) announced that it is permitting the marketing of t...

The risk of psychosis associated with use of amphetamine for attention-deficit/hyperactivity disorde...

Trigeminal nerve stimulation (TNS) may be as effective in treating symptoms of attention deficit/hyp...

Medicaid-enrolled youth aged 5 to 24 years who begin taking high doses of antipsychotics for psychia...

Children who have an older sibling who has been diagnosed with autism spectrum disorder (ASD) are no...

The Food and Drug Administration has approved Jornay PM (extended-release methylphenidate capsules) ...

Welcome to New York City! APA’s 2018 Annual Meeting began in New York today. From now through May 9,...

Stimulants are a preferred option for treating attention-deficit/hyperactivity disorder (ADHD), but ...